Two Aussie biotechs with Capital Raises this week have resulted in their share price to increase, not slump like Kazias after its CR.
I guess, its how the CR is managed, timed and executed that makes the difference
Just my opinion, not advice
- Forums
- ASX - By Stock
- KZA
- Paxalisib GBM AGILE study
Paxalisib GBM AGILE study, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online